Concord Drugs Ltd.

View in App
33.84 +0.15 ▲0.5%

25 September 2023, 04:01:00 PM
Volume: 3,827

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.concorddrugs.in
Market Cap 31.52 Cr.
Enterprise Value(EV) 46.23 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 1.28 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 26.45 Trailing Twelve Months Ending 2023-06
Industry PE 37.43 Trailing Twelve Months Ending 2023-06
Book Value / Share 34.56 Trailing Twelve Months Ending 2023-06
Price to Book Value 0.98 Calculated using Price: 33.84
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.93 Cr. 9,315,470 Shares
FaceValue 10
About Concord Drugs Ltd.
Concord Drugs is engaged in developing new products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery.

Concord Drugs Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Concord Drugs Ltd. Performance

View details >>
1 Day
+0.45%
1 Week
-2.34%
1 Month
-11.27%
3 Month
+22.08%
6 Month
+24.96%
1 Year
+4.44%
2 Year
+15.89%
5 Year
+39.55%
10 Year

Concord Drugs Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 2.72 5.37 12.32 0.94 1.69 1.92 1.41 13.06 5.78
Return on Capital Employed (%) 7.15 11.33 15.90 8.84 7.49 6.17 6.06 15.69 9.30
Return on Assets (%) 0.79 1.41 3.28 0.30 0.40 0.43 0.47 6.08 3.00

Concord Drugs Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 15 13 15 19 19 23 23 27 28 32
Non Curr. Liab. 12 13 17 7 6 4 7 7 5 4
Curr. Liab. 18 28 21 29 81 56 27 16 23 21
Minority Int.
Equity & Liab. 45 54 52 56 106 83 58 50 56 57
Non Curr. Assets 21 19 16 25 14 13 12 14 15 15
Curr. Assets 23 36 37 30 92 70 46 36 42 41
Misc. Exp. not W/O
Total Assets 45 54 52 56 106 83 58 50 56 57

Concord Drugs Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 34 40 51 57 52 48 51 51 59 48
Other Income 0 0 0 0 0 0 0 0 0
Total Income 34 40 51 58 52 48 51 51 59 48
Total Expenditure -31 -33 -42 -52 -47 -44 -48 -48 -53 -43
PBIDT 3 7 8 6 5 4 3 3 6 5
Interest -2 -3 -3 -2 -2 -2 -2 -1 -2 -2
Depreciation -1 -4 -3 -3 -2 -2 -1 -1 -2 -2
Taxation 0 0 -1 0 0 0 0 -1 -1 0
Exceptional Items 4
PAT 0 1 2 0 0 0 0 3 2 1
Adjusted EPS 0 1 2 0 0 1 0 4 2 1

Concord Drugs Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 1 2 2 4 2 7 1 2 2 1
Cash Fr. Inv. -10 -2 -1 0 -1 -2 0 -1 -4 0
Cash Fr. Finan. 8 0 -1 -4 -4 -5 -1 -2 2 2
Net Change -1 0 0 0 -3 0 0 0 0 2
Cash & Cash Eqvt 0 0 0 0 -3 0 0 0 0 3

Concord Drugs Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 44.38 49.00 49.00 49.00 49.00 49.00 49.00 52.13 52.13
Public 55.62 51.00 51.00 51.00 51.00 51.00 51.00 47.87 47.87
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Concord Drugs Ltd. Announcements

View details >>
Tue, 12 Sep 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Newspaper Publication
Fri, 08 Sep 2023
Intimation Of Book Closure For The Purpose Of 28Th Annual General Meeting
Intimation of Book Closure for the purpose of 28th Annual General Meeting
Fri, 08 Sep 2023
Reg. 34 (1) Annual Report.
28th Annual Report

Concord Drugs Ltd. Technical Scans

View details >>
Mon, 25 Sep 2023
High Decrease in 1 Month High Decrease in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months
Closing Near 50 SMA Closing Near 50 SMA
CCI Oversold Zone CCI Oversold Zone

Concord Drugs Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 269,697.25 1,124.05 -0.7%
Divi's Laboratories Ltd. 99,021.11 3,730.05 +0.6%
Cipla Ltd. 95,166.58 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. 90,720.90 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. 73,268.35 5,095.45 +2.2%
Mankind Pharma Ltd. 69,694.38 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. 62,519.33 1,844.85 -0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 31.97 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-06 67.03 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-06 30.62 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.21 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 109.58 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 54.37 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 49.55 1,844.85 -0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.65 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-06 7.55 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-06 3.91 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.70 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.68 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 5.69 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.49 1,844.85 -0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-03 0.02 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,844.85 -0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,844.85 -0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,844.85 -0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,844.85 -0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,124.05 -0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,730.05 +0.6%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,180.05 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,439.40 -1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,095.45 +2.2%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,739.80 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,844.85 -0.3%

Concord Drugs Ltd. FAQ's

What is Concord Drugs share price?
Can I buy Concord Drugs shares now?
What is the Market Cap of Concord Drugs?
What are the key metrics to analyse Concord Drugs?
What is the 52 Week High and Low of Concord Drugs?
What is the trend of Concord Drugs share price?